» Poniard Pharmaceuticals To Present At The 4th Annual Moores UCSD Cancer Center Translational Oncology Symposium
Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, announced that the Company will present information on platinum resistance at the Fourth Annual Moores…